194 related articles for article (PubMed ID: 6208177)
1. Biological markers in gynecologic cancers. An overview.
Dini MM; Miller M
IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177
[No Abstract] [Full Text] [Related]
2. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract].
Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S
Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920
[No Abstract] [Full Text] [Related]
3. [Tumor markers in oncological gynecology].
Vishnevskiĭ AS
Vopr Onkol; 1984; 30(8):23-34. PubMed ID: 6207663
[No Abstract] [Full Text] [Related]
4. Oncofetal and oncoplacental antigens as tumor markers.
Yamauchi S; Miyake H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
[No Abstract] [Full Text] [Related]
5. [Serum markers in malignant diseases].
Peter HH
Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
[No Abstract] [Full Text] [Related]
6. Tumour markers in ovarian cancer.
van Nagell JR
Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
[No Abstract] [Full Text] [Related]
7. [Diagnosis and management of cancer using tumor markers].
Torigoe T; Kato H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1672-6. PubMed ID: 6194233
[No Abstract] [Full Text] [Related]
8. Radioimmunoassay and saturation analysis. Tumor-associated antigens.
Bagshawe KD
Br Med Bull; 1974 Jan; 30(1):68-73. PubMed ID: 4143181
[No Abstract] [Full Text] [Related]
9. Tumour antigens associated with primary mediastinal choriocarcinoma.
Forest JC; Talbot J; Pagé M; Loiselle JM
Can Med Assoc J; 1977 Dec; 117(12):1386-8. PubMed ID: 73406
[TBL] [Abstract][Full Text] [Related]
10. Oncofetal antigens in ovarian cyst fluids.
Kraly DH; Koh SH; Hay DL; Cauchi MN
Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
[TBL] [Abstract][Full Text] [Related]
11. Tumour markers in urology: aids in cancer diagnosis and management.
Wahren B
Urol Res; 1979 Jun; 7(2):57-67. PubMed ID: 89748
[No Abstract] [Full Text] [Related]
12. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated antigens in polyps and carcinoma of the human large bowel.
Skinner JM; Whitehead R
Cancer; 1981 Mar; 47(6):1241-5. PubMed ID: 6164469
[TBL] [Abstract][Full Text] [Related]
14. Antigens, enzymes and hormones. Their roles as tumor markers in gynecologic neoplasia.
Fenoglio CM
Diagn Gynecol Obstet; 1980; 2(1):33-42. PubMed ID: 6162629
[TBL] [Abstract][Full Text] [Related]
15. [Fetal and placental proteins in ovarian cancer].
Tatra G; Ludwig H
Gynakol Rundsch; 1980 Jun; 20 Suppl 2():138-41. PubMed ID: 6163685
[No Abstract] [Full Text] [Related]
16. Tumor markers in the ovarian carcinoma.
Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A
Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
[No Abstract] [Full Text] [Related]
17. Editorial: When is a tumor marker not a tumor marker?
Vaitukaitis JL
N Engl J Med; 1975 Dec; 293(26):1370-1. PubMed ID: 52844
[No Abstract] [Full Text] [Related]
18. [Significance of tumor markers in clinical oncology].
Gericke D; Drahovsky D
Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
[No Abstract] [Full Text] [Related]
19. The immune system in gynecologic malignancies.
Barber HR; Dorsett B
Prog Clin Biol Res; 1981; 70():357-69. PubMed ID: 6171833
[No Abstract] [Full Text] [Related]
20. The value of tumor markers in cancer of the ovary.
Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
